$RKDA
Arcadia Biosciences, Inc.

2024 Q1 Form 10-K Financial Statement

#000095017024038176 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $1.255M $1.170M $5.330M
YoY Change -16.83% 17.0% -46.46%
Cost Of Revenue $820.0K $670.0K $2.856M
YoY Change -0.61% 21.38% -70.86%
Gross Profit $435.0K $500.0K $2.474M
YoY Change -36.4% 11.61% 1506.49%
Gross Profit Margin 34.66% 42.74% 46.42%
Selling, General & Admin $3.189M $3.423M $14.51M
YoY Change -27.39% -18.77% -19.61%
% of Gross Profit 733.1% 684.6% 586.42%
Research & Development $272.0K $332.0K $1.387M
YoY Change -24.23% -33.6% -8.08%
% of Gross Profit 62.53% 66.4% 56.06%
Depreciation & Amortization $51.00K $57.00K $287.0K
YoY Change -28.17% -33.72% -34.62%
% of Gross Profit 11.72% 11.4% 11.6%
Operating Expenses $3.461M $3.755M $15.90M
YoY Change -27.15% -20.34% -18.72%
Operating Profit -$3.064M -$3.255M -$13.42M
YoY Change -24.31% -23.7% -28.67%
Interest Expense $638.0K $736.0K $7.239M
YoY Change -43.94% -50.77% 106.95%
% of Operating Profit
Other Income/Expense, Net $3.000K $12.00K -$6.458M
YoY Change -90.63% -40.0% -19669.7%
Pretax Income -$2.423M -$2.616M -$13.16M
YoY Change -74.18% -39.37% -15.65%
Income Tax $7.000K $8.000K
% Of Pretax Income
Net Earnings -$2.423M -$2.853M -$13.98M
YoY Change -74.18% -32.78% -9.07%
Net Earnings / Revenue -193.07% -243.85% -262.31%
Basic Earnings Per Share -$1.78
Diluted Earnings Per Share -$1.78 -$2.09 -$11.30
COMMON SHARES
Basic Shares Outstanding 1.363M 1.110M 1.237M
Diluted Shares Outstanding 1.362M 1.237M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.501M $11.64M $11.64M
YoY Change -63.04% -43.61% -43.61%
Cash & Equivalents $3.300M $6.518M $6.518M
Short-Term Investments $5.184M $5.124M $5.124M
Other Short-Term Assets $550.0K $858.0K $858.0K
YoY Change -20.63% -4.24% -4.24%
Inventory $1.831M $1.958M $1.958M
Prepaid Expenses
Receivables $760.0K $514.0K $514.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.64M $14.97M $14.97M
YoY Change -57.21% -41.05% -41.05%
LONG-TERM ASSETS
Property, Plant & Equipment $328.0K $1.176M $1.176M
YoY Change -47.27% 67.05% -53.92%
Goodwill
YoY Change
Intangibles $39.00K $39.00K
YoY Change -2.5% -2.5%
Long-Term Investments
YoY Change
Other Assets $164.0K $3.518M $3.518M
YoY Change -0.61% 2032.12% 277.47%
Total Long-Term Assets $4.404M $4.733M $4.733M
YoY Change 37.41% 34.31% 34.31%
TOTAL ASSETS
Total Short-Term Assets $11.64M $14.97M $14.97M
Total Long-Term Assets $4.404M $4.733M $4.733M
Total Assets $16.05M $19.71M $19.71M
YoY Change -47.23% -31.87% -31.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.807M $2.468M $859.0K
YoY Change -35.46% -15.74% -12.26%
Accrued Expenses $801.0K $852.0K $2.461M
YoY Change -21.01% -15.64% -16.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.878M $3.590M $3.590M
YoY Change -29.75% -14.71% -14.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.000M $3.412M $3.412M
YoY Change 0.0% 70.6% -10.52%
Total Long-Term Liabilities $2.000M $3.412M $3.412M
YoY Change 0.0% 70.6% -10.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.878M $3.590M $3.590M
Total Long-Term Liabilities $2.000M $3.412M $3.412M
Total Liabilities $5.563M $6.864M $6.864M
YoY Change -59.45% -14.44% -12.99%
SHAREHOLDERS EQUITY
Retained Earnings -$274.3M -$271.8M
YoY Change 2.66% 5.39%
Common Stock $284.7M $284.6M
YoY Change 0.23% 2.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.62M $12.84M $12.84M
YoY Change
Total Liabilities & Shareholders Equity $16.05M $19.71M $19.71M
YoY Change -47.23% -31.87% -31.87%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$2.423M -$2.853M -$13.98M
YoY Change -74.18% -32.78% -9.07%
Depreciation, Depletion And Amortization $51.00K $57.00K $287.0K
YoY Change -28.17% -33.72% -34.62%
Cash From Operating Activities -$3.200M -$4.144M -$15.29M
YoY Change -8.57% 75.89% 9.24%
INVESTING ACTIVITIES
Capital Expenditures $13.00K -$5.000K $5.000K
YoY Change -119.23% -93.06%
Acquisitions
YoY Change
Other Investing Activities $17.00K $51.00K -$4.339M
YoY Change -94.6% -83.39% -391.4%
Cash From Investing Activities $4.000K $56.00K -$4.344M
YoY Change -98.73% -80.07% -406.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.009M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.000K 2.000K 5.512M
YoY Change -99.91% 21.97%
NET CHANGE
Cash From Operating Activities -3.200M -4.144M -15.29M
Cash From Investing Activities 4.000K 56.00K -4.344M
Cash From Financing Activities 5.000K 2.000K 5.512M
Net Change In Cash -3.201M -4.086M -14.13M
YoY Change -235.98% 96.92% 75.67%
FREE CASH FLOW
Cash From Operating Activities -$3.200M -$4.144M -$15.29M
Capital Expenditures $13.00K -$5.000K $5.000K
Free Cash Flow -$3.213M -$4.139M -$15.30M
YoY Change -8.2% 73.76% 8.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001469443
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-37383
CY2023 dei Entity Registrant Name
EntityRegistrantName
Arcadia Biosciences, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0571538
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
5950 Sherry Lane
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 215
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75225
CY2023 dei City Area Code
CityAreaCode
214
CY2023 dei Local Phone Number
LocalPhoneNumber
974-8921
CY2023 dei Security12b Title
Security12bTitle
Common
CY2023 dei Trading Symbol
TradingSymbol
RKDA
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
4169072
CY2023Q2 us-gaap Share Price
SharePrice
3.88
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1362840
CY2023 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6518000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20644000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
5124000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3000
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
514000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1221000
CY2023Q4 us-gaap Inventory Net
InventoryNet
1958000
CY2022Q4 us-gaap Inventory Net
InventoryNet
2321000
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
51000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
87000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
807000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
795000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
330000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14972000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
25398000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
680000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
792000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1848000
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3354000
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
767000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
164000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
165000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
24000
CY2023Q4 us-gaap Assets
Assets
19705000
CY2022Q4 us-gaap Assets
Assets
28922000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2410000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2855000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
852000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1010000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
26000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3590000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4209000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
155000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1007000
CY2023Q4 rkda Common Stock Warrant And Option Liabilities
CommonStockWarrantAndOptionLiabilities
1257000
CY2022Q4 rkda Common Stock Warrant And Option Liabilities
CommonStockWarrantAndOptionLiabilities
806000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000000
CY2023Q4 us-gaap Liabilities
Liabilities
7002000
CY2022Q4 us-gaap Liabilities
Liabilities
8022000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1285337
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1285337
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
616079
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
616079
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
65000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
65000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
284515000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
278827000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
101000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-271840000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-257859000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12841000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21033000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-138000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-133000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12703000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20900000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19705000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28922000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5330000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7418000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3300000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6101000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1387000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1509000
CY2023 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1138000
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
141000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-70000
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
40000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
314000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
160000
CY2023 rkda Impairment Of Right Of Use Asset
ImpairmentOfRightOfUseAsset
113000
CY2022 rkda Impairment Of Right Of Use Asset
ImpairmentOfRightOfUseAsset
0
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14508000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15036000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
19268000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
21425000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-13938000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-14007000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
695000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
289000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2023 rkda Gain Loss On Private Placement
GainLossOnPrivatePlacement
-6076000
CY2022 rkda Gain Loss On Private Placement
GainLossOnPrivatePlacement
0
CY2023 rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
6544000
CY2022 rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
3209000
CY2023 rkda Issuance And Offering Costs Allocated To Liability Classified Options
IssuanceAndOfferingCostsAllocatedToLiabilityClassifiedOptions
430000
CY2022 rkda Issuance And Offering Costs Allocated To Liability Classified Options
IssuanceAndOfferingCostsAllocatedToLiabilityClassifiedOptions
314000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13157000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10814000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-13165000
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10828000
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-821000
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4784000
CY2023 us-gaap Profit Loss
ProfitLoss
-13986000
CY2022 us-gaap Profit Loss
ProfitLoss
-15612000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-236000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13981000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15376000
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-10.64
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-10.64
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-17.67
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-17.67
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.66
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.66
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-7.98
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-7.98
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1236934
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1236934
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
599389
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599389
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
101000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
101000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1118000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13880000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15376000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31196000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1106000
CY2022 us-gaap Profit Loss
ProfitLoss
-15612000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20900000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12000
CY2023 rkda Stock Issued During Period Value Related To Exercise Of Services And Performance Warrants
StockIssuedDuringPeriodValueRelatedToExerciseOfServicesAndPerformanceWarrants
0
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
717000
CY2023 us-gaap Profit Loss
ProfitLoss
-13986000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12703000
CY2023 us-gaap Profit Loss
ProfitLoss
-13986000
CY2022 us-gaap Profit Loss
ProfitLoss
-15612000
CY2023 rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
6544000
CY2022 rkda Change In Fair Value Of Common Stock Warrant And Option Liabilities
ChangeInFairValueOfCommonStockWarrantAndOptionLiabilities
3209000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-0
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-70000
CY2023 rkda Issuance And Offering Costs Allocated To Liability Classified Options
IssuanceAndOfferingCostsAllocatedToLiabilityClassifiedOptions
430000
CY2022 rkda Issuance And Offering Costs Allocated To Liability Classified Options
IssuanceAndOfferingCostsAllocatedToLiabilityClassifiedOptions
314000
CY2023 rkda Gain Loss On Private Placement
GainLossOnPrivatePlacement
-6076000
CY2022 rkda Gain Loss On Private Placement
GainLossOnPrivatePlacement
0
CY2023 us-gaap Depreciation
Depreciation
287000
CY2022 us-gaap Depreciation
Depreciation
439000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
697000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
884000
CY2023 rkda Disposal Group Including Discontinued Operation Impairment Of Intangible Assets
DisposalGroupIncludingDiscontinuedOperationImpairmentOfIntangibleAssets
0
CY2022 rkda Disposal Group Including Discontinued Operation Impairment Of Intangible Assets
DisposalGroupIncludingDiscontinuedOperationImpairmentOfIntangibleAssets
404000
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
40000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
314000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
717000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1106000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
60000
CY2023 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
1138000
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
444000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
2471000
CY2023 rkda Disposal Group Including Discontinued Operation Impairment Of Property And Equipment
DisposalGroupIncludingDiscontinuedOperationImpairmentOfPropertyAndEquipment
0
CY2022 rkda Disposal Group Including Discontinued Operation Impairment Of Property And Equipment
DisposalGroupIncludingDiscontinuedOperationImpairmentOfPropertyAndEquipment
530000
CY2023 rkda Impairment Of Right Of Use Asset
ImpairmentOfRightOfUseAsset
113000
CY2022 rkda Impairment Of Right Of Use Asset
ImpairmentOfRightOfUseAsset
0
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-184000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-592000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2419000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-91000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-16000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-522000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-757000
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
10000
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-16000
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6000
CY2023 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-764000
CY2022 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-932000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15294000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13977000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
115000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
920000
CY2023 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
569000
CY2022 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
569000
CY2023 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
2502000
CY2022 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72000
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7525000
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4344000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1417000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
12000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
7000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5512000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4519000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14126000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8041000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20644000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28685000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6518000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20644000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
114000
CY2023 rkda Proceeds From Sale Of Property And Equipment In Accounts Receivable And Other Receivables
ProceedsFromSaleOfPropertyAndEquipmentInAccountsReceivableAndOtherReceivables
8000
CY2022 rkda Proceeds From Sale Of Property And Equipment In Accounts Receivable And Other Receivables
ProceedsFromSaleOfPropertyAndEquipmentInAccountsReceivableAndOtherReceivables
19000
CY2023 rkda Proceeds From Sale Of Equity Method Investments In Accounts And Other Receivable
ProceedsFromSaleOfEquityMethodInvestmentsInAccountsAndOtherReceivable
0
CY2022 rkda Proceeds From Sale Of Equity Method Investments In Accounts And Other Receivable
ProceedsFromSaleOfEquityMethodInvestmentsInAccountsAndOtherReceivable
569000
CY2023 rkda Entity Place Of Incorporation
EntityPlaceOfIncorporation
Arizona
CY2023 rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
CY2023 rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
CY2023 rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
In February 2023, the Company’s board of directors approved a reverse split of 40:1 on the Company’s issued and outstanding common stock.
CY2023 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
19118
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-271800000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6500000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
5100000
CY2023 us-gaap Profit Loss
ProfitLoss
-14000000
CY2022 us-gaap Profit Loss
ProfitLoss
-15600000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15300000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14000000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-236000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in the Company’s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management included the determination of revenue recognition, the provision for income taxes, net realizable value of inventory, and fair value of the preferred investment option and contingent liabilities. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of risk</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">are </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate its credit risks by spreading such risks across multiple counterparties and monitoring the risk profiles of these counterparties.</span></p>
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
717000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1106000
CY2022Q4 rkda Debt And Equity Securities Amortized Cost Basis
DebtAndEquitySecuritiesAmortizedCostBasis
18620000
CY2022Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
444000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
2500000
CY2022Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2022Q4 rkda Debt And Equity Securities
DebtAndEquitySecurities
18620000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
10049000
CY2023Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
484000
CY2022Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
610000
CY2023Q4 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
55000
CY2022Q4 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
0
CY2023Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
4773000
CY2022Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
2478000
CY2023Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
5312000
CY2022Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
3088000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2893000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3491000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2509000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2811000
CY2023Q4 rkda Property Plant And Equipment Assets Held For Sale Net
PropertyPlantAndEquipmentAssetsHeldForSaleNet
384000
CY2022Q4 rkda Property Plant And Equipment Assets Held For Sale Net
PropertyPlantAndEquipmentAssetsHeldForSaleNet
680000
CY2023 us-gaap Depreciation
Depreciation
287000
CY2022 us-gaap Depreciation
Depreciation
439000
CY2023Q4 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
51000
CY2022Q4 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
87000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
40000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
115000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
314000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
920000
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
530000
CY2023Q4 rkda Debt And Equity Securities Amortized Cost Basis
DebtAndEquitySecuritiesAmortizedCostBasis
9948000
CY2023Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
101000
CY2023Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2023Q4 rkda Debt And Equity Securities
DebtAndEquitySecurities
10049000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
18620000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-236000
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
801000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
905000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1303000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1373000
CY2023Q4 rkda Accrued Inventory
AccruedInventory
0
CY2022Q4 rkda Accrued Inventory
AccruedInventory
69000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
4000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6000
CY2023Q4 rkda Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
0
CY2022Q4 rkda Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
8000
CY2023Q4 rkda Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
0
CY2022Q4 rkda Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
28000
CY2023Q4 rkda Accrued Audit And Tax Fees
AccruedAuditAndTaxFees
218000
CY2022Q4 rkda Accrued Audit And Tax Fees
AccruedAuditAndTaxFees
99000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
40000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
69000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
298000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2410000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2855000
CY2022 rkda Stock Issued During Period Shares Related To Exercise Of Warrants
StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants
0
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
342570
CY2023 rkda Stock Issued During Period Shares Related To Exercise Of Warrants
StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants
-482647
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
341957
CY2023 rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35554
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
211.2
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
33408
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44
CY2022 rkda Share Based Compensation Arrangement By Share Based Payment Award Grants Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsOutstandingIntrinsicValue
11880000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6658
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
91.6
CY2022 rkda Share Based Compensation Arrangement By Share Based Payment Award Forfeiture Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitureOutstandingIntrinsicValue
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2302
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
644.8
CY2022 rkda Share Based Compensation Arrangement By Share Based Payment Award Expired Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpiredOutstandingIntrinsicValue
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
60002
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
114.8
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
26021
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.38
CY2023 rkda Share Based Compensation Arrangement By Share Based Payment Award Grants Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsOutstandingIntrinsicValue
0
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5644
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
29.58
CY2023 rkda Share Based Compensation Arrangement By Share Based Payment Award Forfeiture Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitureOutstandingIntrinsicValue
39062000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
301
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
121.05
CY2023 rkda Share Based Compensation Arrangement By Share Based Payment Award Expired Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpiredOutstandingIntrinsicValue
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
80078
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
85.3
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
74608
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
89.85
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
41735
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
139.82
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
623000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.72
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
38.5
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
717000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1100000
CY2023 rkda Operating Lease Term Expiration Month And Year
OperatingLeaseTermExpirationMonthAndYear
2024-05
CY2023 rkda Payments For Termination Fees
PaymentsForTerminationFees
47000
CY2023 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Some leases (the Dallas and Davis offices and a warehouse) include one or more options to renew, with renewal terms that can extend the lease term from one to six years
CY2023 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
792000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1848000
CY2023Q4 rkda Operating Lease Assets
OperatingLeaseAssets
792000
CY2022Q4 rkda Operating Lease Assets
OperatingLeaseAssets
1848000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
852000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1010000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
155000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1007000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1007000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2017000
CY2023 us-gaap Lease Cost
LeaseCost
326000
CY2022 us-gaap Lease Cost
LeaseCost
650000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
886000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
156000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1042000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
35000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1007000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13978000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15598000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2023 rkda Income Loss From Continuing Operations And Discontinued Operations Before Income Taxes
IncomeLossFromContinuingOperationsAndDiscontinuedOperationsBeforeIncomeTaxes
-13978000
CY2022 rkda Income Loss From Continuing Operations And Discontinued Operations Before Income Taxes
IncomeLossFromContinuingOperationsAndDiscontinuedOperationsBeforeIncomeTaxes
-15598000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
7000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
13000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.16
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.266
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.409
CY2023 rkda Effective Income Tax Rate Reconciliation Derivative Liabilities Percentage
EffectiveIncomeTaxRateReconciliationDerivativeLiabilitiesPercentage
0.098
CY2022 rkda Effective Income Tax Rate Reconciliation Derivative Liabilities Percentage
EffectiveIncomeTaxRateReconciliationDerivativeLiabilitiesPercentage
0.041
CY2023 rkda Effective Income Tax Rate Reconciliation Pipe Transactions Percentage
EffectiveIncomeTaxRateReconciliationPipeTransactionsPercentage
-0.098
CY2022 rkda Effective Income Tax Rate Reconciliation Pipe Transactions Percentage
EffectiveIncomeTaxRateReconciliationPipeTransactionsPercentage
0
CY2023 rkda Effective Income Tax Rate Reconciliation Contingent Consideration Release
EffectiveIncomeTaxRateReconciliationContingentConsiderationRelease
0
CY2022 rkda Effective Income Tax Rate Reconciliation Contingent Consideration Release
EffectiveIncomeTaxRateReconciliationContingentConsiderationRelease
0.001
CY2023 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.005
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.001
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23160000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19654000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4654000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4541000
CY2023Q4 rkda Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
342000
CY2022Q4 rkda Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
296000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
87000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
54000
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
102000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
445000
CY2023Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2022Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
2000
CY2023Q4 rkda Deferred Tax Asset Income From Partnerships
DeferredTaxAssetIncomeFromPartnerships
231000
CY2022Q4 rkda Deferred Tax Asset Income From Partnerships
DeferredTaxAssetIncomeFromPartnerships
97000
CY2023Q4 rkda Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
261000
CY2022Q4 rkda Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
531000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
147000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
65000
CY2023Q4 rkda Deferred Tax Assets Amortized Intangibles
DeferredTaxAssetsAmortizedIntangibles
755000
CY2022Q4 rkda Deferred Tax Assets Amortized Intangibles
DeferredTaxAssetsAmortizedIntangibles
819000
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
358000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
393000
CY2023Q4 rkda Deferred Tax Assets Section One Seven Four Capitalization
DeferredTaxAssetsSectionOneSevenFourCapitalization
583000
CY2022Q4 rkda Deferred Tax Assets Section One Seven Four Capitalization
DeferredTaxAssetsSectionOneSevenFourCapitalization
340000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
30699000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
27253000
CY2023Q4 rkda Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
205000
CY2022Q4 rkda Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
486000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
205000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
486000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30494000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26767000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3700000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6300000
CY2023 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
it has not forfeited the right to carryforward tax losses up to 20 years
CY2023 rkda Income Tax Examination Year Subject Under Examination
IncomeTaxExaminationYearSubjectUnderExamination
2004
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
CY2023 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
Employees’ rights to employer contributions vest on the one-year anniversary of their date of employment.
CY2023 rkda Defined Benefit Plan Contribution Vesting Period
DefinedBenefitPlanContributionVestingPeriod
P1Y
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5330000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7418000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1836987
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
469726
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 rkda Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2023Q4 rkda Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2023 dei Auditor Location
AuditorLocation
Tempe, AZ

Files In Submission

Name View Source Status
0000950170-24-038176-index-headers.html Edgar Link pending
0000950170-24-038176-index.html Edgar Link pending
0000950170-24-038176.txt Edgar Link pending
0000950170-24-038176-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-20231231.htm Edgar Link pending
rkda-20231231.xsd Edgar Link pending
rkda-ex23_1.htm Edgar Link pending
rkda-ex31_1.htm Edgar Link pending
rkda-ex31_2.htm Edgar Link pending
rkda-ex32_1.htm Edgar Link pending
rkda-ex32_2.htm Edgar Link pending
rkda-ex4_7.htm Edgar Link pending
rkda-ex97_1.htm Edgar Link pending
Show.js Edgar Link pending
rkda-20231231_htm.xml Edgar Link completed